Innocoll Holdings Limited

Companies that are developing local anesthetic products intended to have a long-acting effect should collect trial data on “clinically meaningful outcomes,” such as reduction in hospitalization, even

With the Nasdaq Biotechnology Index (NBI) and the closely watched XBI biotech fund down 13.2% and 18.9%, respectively, so far this year and 20.3% and 43.6% below where they were trading a year ago, ma

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche/Genentech Bring In Cell Therapy C

The US Food and Drug Administration’s recent approvals include three new molecular entities, bring the Center for Drug Evaluation and Research’s novel approval count for the year to 40. The new novel